1. Home
  2. LPL vs BEAM Comparison

LPL vs BEAM Comparison

Compare LPL & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

N/A

Current Price

$3.31

Market Cap

3.2B

Sector

Technology

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$28.20

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPL
BEAM
Founded
1985
2017
Country
South Korea
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
LPL
BEAM
Price
$3.31
$28.20
Analyst Decision
Hold
Buy
Analyst Count
1
12
Target Price
N/A
$50.75
AVG Volume (30 Days)
2.9M
1.7M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.31
EPS
N/A
N/A
Revenue
N/A
$24,000.00
Revenue This Year
$1.35
N/A
Revenue Next Year
$2.94
$33.77
P/E Ratio
$25.64
N/A
Revenue Growth
N/A
33.33
52 Week Low
$2.76
$16.03
52 Week High
$5.83
$38.26

Technical Indicators

Market Signals
Indicator
LPL
BEAM
Relative Strength Index (RSI) 45.99 52.00
Support Level $2.76 $26.23
Resistance Level $4.37 $28.96
Average True Range (ATR) 0.10 1.32
MACD 0.04 0.39
Stochastic Oscillator 46.96 80.96

Price Performance

Historical Comparison
LPL
BEAM

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: